Q5129 — Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg

What the market charges

Across 1,080 negotiated rates, the middle 80% fall between $22 and $81, with a median of $36.

What Medicare pays

Medicare allowed an average of $64 for this code, across 362,529 services billed by 88 providers. At the median, the market charges less than Medicare pays for this code — 44% less.

Where this is billed, and what it costs there

The states billing Q5129 most, by Medicare service volume, each compared against the national average of $64. Each links to the providers Mishe lists there.

  • Florida — 24 providers billed it, Medicare allowed $64 — level with the national average
  • California — 16 providers billed it, Medicare allowed $64 — level with the national average
  • Kansas — 13 providers billed it, Medicare allowed $64 — level with the national average
  • Arkansas — 8 providers billed it, Medicare allowed $63 — 2% below the national average
  • Texas — 7 providers billed it, Medicare allowed $64 — level with the national average

Deploy this for your team

Every figure on this page came from published payer and Medicare data, assembled by Mishe. The same pricing, claim-editing and care-pathway intelligence runs underneath the plans Mishe operates.

Take back healthcare.